| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 2 | 1 | — | 1 | 2 | — | 1 | 1 | — | 3 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 4.80 |
—
—
—
|
| 2025 | 4.16 |
—
—
—
—
|
| 2024 | 3.30 |
—
—
—
—
|
| 2023 | 2.60 |
—
—
—
—
|
| 2022 | 2.20 |
—
—
—
—
|
| 2021 | 1.88 |
—
—
—
—
|
| 2020 | 1.60 |
—
—
—
—
|
| 2019 | 1.36 |
—
—
—
—
|
| 2018 | 1.00 |
—
—
—
—
|
| 2017 | 0.78 |
—
—
—
—
|
| 2016 | 0.70 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 594.15 | 687.82 | 756.23 | 600.18 |
| Receivables | 3,284.99 | 3,026.77 | 2,840.12 | 2,450.75 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 3,879.14 | 3,714.59 | 3,596.35 | 3,050.93 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 7,270.70 | 7,007.02 | 7,329.06 | 7,308.90 |
| ST’ Debt | 1,980.30 | 1,898.07 | 1,770.43 | 1,669.01 |
| Other | 435.09 | 402.32 | 356.43 | 344.44 |
| 9,686.10 | 9,307.41 | 9,455.92 | 9,322.34 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 872.69 | 865.07 | — | — |
—
|
| ’25 | 804.84 | 793.33 | 839.85 | 853.68 |
3,291.71
|
| ’24 | 735.95 | 790.96 | 774.13 | 788.11 |
3,089.14
|
| ’23 | 690.04 | 688.39 | 697.50 | 672.59 |
2,748.51
|
| ’22 | 691.23 | 668.68 | 673.29 | 624.25 |
2,657.45
|
| ’21 | 637.71 | 654.69 | 693.24 | 724.10 |
2,709.73
|
| ’20 | 524.94 | 525.82 | 568.46 | 598.33 |
2,217.54
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 156.79 | 193.82 | — | — |
—
|
| ’25 | 197.47 | 162.58 | 202.89 | 338.24 |
901.18
|
| ’24 | 210.90 | 173.28 | 207.27 | 270.64 |
862.09
|
| ’23 | 175.95 | 135.75 | 139.77 | 241.06 |
692.52
|
| ’22 | 214.30 | 170.18 | 166.80 | 206.39 |
757.67
|
| ’21 | 119.46 | 155.34 | 160.33 | 221.84 |
656.96
|
| ’20 | 131.52 | 184.90 | 87.53 | 239.46 |
643.42
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 147.73 | 167.09 | — | — |
—
|
| ’25 | 188.74 | 159.04 | 197.70 | 329.64 |
875.13
|
| ’24 | 202.51 | 169.07 | 193.22 | 268.06 |
832.86
|
| ’23 | 168.09 | 133.37 | 136.37 | 220.79 |
658.62
|
| ’22 | 206.62 | 163.50 | 157.21 | 204.53 |
731.86
|
| ’21 | 109.28 | 153.42 | 151.00 | 218.58 |
632.27
|
| ’20 | 121.60 | 175.45 | 84.45 | 234.29 |
615.80
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 5.97 | 6.45 | — | — |
—
|
| ’25 | 5.05 | 5.40 | 6.35 | 6.13 |
22.91
|
| ’24 | 3.93 | 0.03 | 4.83 | 4.96 |
13.71
|
| ’23 | 3.38 | 3.97 | 4.23 | 4.30 |
15.94
|
| ’22 | 2.06 | 2.79 | 1.37 | 3.54 |
9.74
|
| ’21 | 2.46 | 3.22 | 2.82 | 0.87 |
9.38
|
| ’20 | 1.75 | 2.51 | 2.81 | 2.52 |
9.57
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 110.22 | 141.11 | 184.76 | 230.98 | — | — | — |
Low Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 159.47 | 220.00 | 307.91 | 298.75 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,381 | 3,450 | 2,874 | 2,833 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.12 | 0.80 | 1.07 | 1.16 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,657.45 | 2,748.51 | 3,089.14 | 3,291.71 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 75.00% | 75.38% | 78.82% | 80.21% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 718.66 | 771.74 | 939.25 | 974.56 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.04% | 28.08% | 30.40% | 29.61% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 467.03 | 576.60 | 470.52 | 751.23 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 359.13 | 305.75 | 571.76 | 338.78 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 69.94 | 76.45 | 90.48 | 100.87 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 9.77 | 15.97 | 13.73 | 22.95 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.94 | 19.26 | 25.25 | 27.62 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.68) | (0.94) | (0.86) | (0.80) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.26 | 18.32 | 24.39 | 26.82 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 53.46 | 57.46 | 66.17 | 74.95 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.00 | 35.95 | 34.14 | 32.63 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 14.48 | 13.09 | 19.70 | 11.25 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.03 | 2.72 | 3.00 | 2.56 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.66 | 3.62 | 4.10 | 3.45 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.39 | 3.71 | 3.82 | 3.27 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 12.32 | 15.47 | 14.17 | 12.31 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 757.67 | 692.52 | 862.09 | 901.18 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (25.80) | (33.90) | (29.23) | (26.05) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 731.86 | 658.62 | 832.86 | 875.13 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5,219.62) | (5,806.96) | (5,592.82) | (5,859.57) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4,111.37 | 1,980.30 | 1,898.07 | 1,770.43 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,622.13 | 1,386.15 | 1,210.25 | 1,014.21 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,031.25 | 2,065.97 | 2,259.04 | 2,445.90 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.07% | 3.89% | 3.18% | 5.08% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.94% | 13.97% | 16.92% | 17.60% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.95% | 28.15% | 21.76% | 31.93% | — | — | — |
ROE
|
Primerica, Inc. (PRI) has delivered impressive long-term growth through its asset-light, multi-level marketing model distributing term life insurance, investments, and mortgages. From 2016 to 2024, revenue compounded at 9.2% to $3.09 billion, while EPS surged 14.6% annually to $13.73, amplified by disciplined share repurchases reducing shares outstanding by 28%. Operational efficiency shines with rebounding revenue per employee at $1.07 million, margin expansion to 30.4% EBT, and ROIC jumping to 16.9%, underscoring a resilient business even through pandemic disruptions.
The balance sheet fortifies this profile, with net debt slashed 67% to $1.21 billion and robust free cash flow of $24.39 per share funding buybacks and modest dividends. Valuation appears reasonable at 11.9x forward PE and 14x EV/FCF, with stock price tightly correlated to per-share metrics and analyst targets suggesting 18% average upside amid projected 2025-2026 EPS growth to $23.47. However, recent insider selling totaling $4.7 million without buys introduces caution, potentially signaling near-term sentiment risks.
While tailwinds like demographic shifts and rate normalization support 15-20% EPS CAGR potential, investors must monitor regulatory pressures on its sales model, competition, and working capital strains. PRI’s steady compounding and downside protection merit attention, but a conservative stance weighs these fundamentals against execution uncertainties.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.